Washington Trust’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-47
Closed -$541 956
2023
Q1
$541 Sell
47
-144
-75% -$1.78K ﹤0.01% 917
2022
Q4
$2.37K Hold
191
﹤0.01% 786
2022
Q3
$3K Hold
191
﹤0.01% 773
2022
Q2
$3K Hold
191
﹤0.01% 776
2022
Q1
$3K Hold
191
﹤0.01% 794
2021
Q4
$3K Hold
191
﹤0.01% 799
2021
Q3
$3K Hold
191
﹤0.01% 919
2021
Q2
$3K Hold
191
﹤0.01% 916
2021
Q1
$3K Hold
191
﹤0.01% 874
2020
Q4
$3K Buy
+191
New +$3.05K ﹤0.01% 845

Other funds holding SBRA

Washington Trust's SBRA Position: Q2 2023 in Review

Washington Trust sold out of Sabra Healthcare REIT (SBRA) in Q2 2023, closing a stake of 47 shares — an estimated $541 sold.

Washington Trust first reported a position in SBRA in Q4 2020 and held it in 10 quarters. The position peaked at $3K in Q3 2022. 325 funds tracked by Wall St. Rank hold SBRA as of Q2 2023.

  • Washington Trust reported no remaining Sabra Healthcare REIT position as of Q2 2023 after selling out during the quarter.
  • Washington Trust sold 47 Sabra Healthcare REIT shares in Q2 2023, an estimated $541.
  • Washington Trust first reported a position in Sabra Healthcare REIT in Q4 2020 and held it in 10 quarters.
  • Washington Trust's Sabra Healthcare REIT position peaked at $3K in Q3 2022.
  • 325 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q2 2023.

Based on Washington Trust's 13F filing for Q2 2023, filed 27 Jul 2023.